Nature’s Sunshine leads the list of last week’s life science gainers on the NASDAQ, followed by BioDelivery Sciences, Immunogen, AVEO Pharmaceuticals and Alnylam Pharmaceuticals.
Pharmaceutical companies work towards achieving the goal of bringing new cures or treatments to the market and improve the treatment available for patients.
DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on developing new cancer therapies, today announced new mechanism of action (MOA) data for its anti-cancer product candidate, VAL-083 (dianhydrogalactitol), a “first-in-class” small-molecule DNA-targeting agent in temozolomide (Temodar™)-resistant GBM, at the World Federation of Neuro-Oncology Societies (WFNOS).
By Pia Rivera
MMJ PhytoTech Limited (ASX:MMJ) (“MMJ” or “the Company”) is pleased to advise that Harvest One Capital Inc. (TSXV:WON.H) (“Harvest One”) has received conditional approval from the TSX Venture Exchange (“TSX-V”) for the acquisition of MMJ’s wholly-owned subsidiaries United Greeneries Holdings Ltd (“United Greeneries”) and Satipharm AG (“Satipharm”).
Invictus MD (TSXV:IMH) is pleased to announce that AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), will provide their unique products in Canopy Growth Corporation’s (TSX:WEED) (“Canopy Growth”) curated CraftGrow line on Tweed Main Street’s online store, that brings high
Invictus MD (TSXV:IMH) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.787 million in revenue for the 9 months ending March 31, 2017, with a gross margin of $907,864, representing a 50.8% gross margin compared to the same
Inovio Pharmaceuticals announced its Ebola vaccine showed promising preliminary results from an expanded Phase I study.
Acreage Pharms Ltd., which Invictus MD (CNX:IMH). has the option to now acquire 100 per cent of and expects to exercise in short order, has begun its new cultivation cycle, having received its licence to cultivate under the access to cannabis for medical purposes regulations (ACMPR); Acreage is firmly committed
Invictus MD (CNX:IMH), Canada’s cannabis company, is pleased to announce that its common shares will be delisted from the Canadian Securities Exchange after the close of trading on March 30, 2017 and will be listed on the TSX Venture Exchange (“TSXV”) commencing at the open of trading on March 31,